drug pricing

Three big Congressional hearings next week to set the tenor on Covid-19, drug prices, and ARPA-H
Three big Congressional hearings next week to set the tenor on Covid-19, drug prices, and ARPA-H
Endpoints
congress
COVID-19
drug pricing
Medicare
ARPA-H
Flag link:
Sanofi's net prices keep slipping—despite list price hikes—thanks to billions in rebates
Sanofi's net prices keep slipping—despite list price hikes—thanks to billions in rebates
Fierce Pharma
Sanofi
drug pricing
drug rebates
Flag link:
Biden continues his pledge for Medicare drug price negotiations in State of the Union speech
Biden continues his pledge for Medicare drug price negotiations in State of the Union speech
Endpoints
Joe Biden
drug pricing
Flag link:
Pfizer to join J&J, Moderna in shareholder vote showdown on vaccine pricing strategy, manufacturing tech sharing
Pfizer to join J&J, Moderna in shareholder vote showdown on vaccine pricing strategy, manufacturing tech sharing
Fierce Pharma
Pfizer
JNJ
Moderna Therapeutics
COVID-19
vaccines
drug pricing
Flag link:
When the $10K brand name drug is more affordable than its $450 generic: How PBMs control the system
When the $10K brand name drug is more affordable than its $450 generic: How PBMs control the system
Endpoints
PBMs
drug pricing
generics
Flag link:
FTC deadlocks on vote to launch study into PBM practices
FTC deadlocks on vote to launch study into PBM practices
BioPharma Dive
FTC
PBMs
drug pricing
Flag link:
FTC plots a look into the competitive impact of PBMs on drug prices, pharmacies
FTC plots a look into the competitive impact of PBMs on drug prices, pharmacies
Endpoints
FTC
PBMs
drug pricing
competition
Flag link:
A rarity for ICER: Cost watchdog says Covid-19 therapeutics appropriately priced in the US
A rarity for ICER: Cost watchdog says Covid-19 therapeutics appropriately priced in the US
Endpoints
ICER
drug pricing
COVID-19
Flag link:
Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx
Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx
Fierce Pharma
Pfizer
GSK
Teva Pharmaceutical
drug pricing
Flag link:
Tales of the Unsurprised: Brand-Name Drug Prices Fell for the Fourth Consecutive Year
Tales of the Unsurprised: Brand-Name Drug Prices Fell for the Fourth Consecutive Year
Drug Channels
drug pricing
drug prices
Flag link:
What’s Behind Biogen’s Move To Cut Prices On Its Controversial Alzheimer’s Drug Aduhelm?
What’s Behind Biogen’s Move To Cut Prices On Its Controversial Alzheimer’s Drug Aduhelm?
Forbes
Biogen
Aduhelm
drug pricing
Alzheimer's disease
Flag link:
Biogen halves Aduhelm's price and plots cost cuts as Medicare decision on controversial Alzheimer's drug nears
Biogen halves Aduhelm's price and plots cost cuts as Medicare decision on controversial Alzheimer's drug nears
Fierce Pharma
Biogen
Aduhelm
Alzheimer's disease
drug pricing
layoffs
Flag link:
Joe Manchin quashes any immediate hopes for major drug pricing reforms
Joe Manchin quashes any immediate hopes for major drug pricing reforms
Endpoints
drug pricing
Build Back Better Act
Joe Biden
Joe Manchin
Flag link:
Prescription drug price reform on the line in Biden’s big social spending bill
Prescription drug price reform on the line in Biden’s big social spending bill
Virginia Mercury
drug pricing
Build Back Better Act
Joe Biden
legislation
Flag link:
Generic drugs and biosimilars get last-minute reprieve from rebates with Senate tweaks to Build Back Better Act
Generic drugs and biosimilars get last-minute reprieve from rebates with Senate tweaks to Build Back Better Act
Endpoints
Senate
drug pricing
Joe Biden
Build Back Better Act
drug rebates
Flag link:
Drug prices soared by nearly 4 times the inflation rate in 5 years, House investigation finds
Drug prices soared by nearly 4 times the inflation rate in 5 years, House investigation finds
Beckers Hospital Review
drug pricing
inflation
Flag link:
Biden touts drug cost measures in spending bill
Biden touts drug cost measures in spending bill
Beckers Hospital Review
Joe Biden
Build Back Better Act
drug pricing
insulin
Medicare
Flag link:
Drugmakers cut prices on average by more than 60% to get on China's 2022 NDRL list — report
Drugmakers cut prices on average by more than 60% to get on China's 2022 NDRL list — report
Endpoints
China
drug pricing
NRDL
Flag link:
Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China's latest cost squeeze
Novo Nordisk, Sanofi and Eli Lilly cut insulin prices and lose share in China's latest cost squeeze
Fierce Pharma
Novo Nordisk
Sanofi
Eli Lilly
insulin
China
diabetes
drug pricing
Flag link:
Time for change: PhRMA survey shows insurance creates barriers to healthcare in US
Time for change: PhRMA survey shows insurance creates barriers to healthcare in US
Pharmaforum
PhRMA
insurers
drug pricing
affordability
Flag link:

Pages